Skip to content

Cognitive and motor development, nerve function, somatic growth and (pubertal) development, and (spontaneous) thyroid function in 10,5 years old Down syndrome children after thyroxine or placebo treatment until the age of 2 years.

Cognitive and motor development, nerve function, somatic growth and (pubertal) development, and (spontaneous) thyroid function in 10,5 years old Down syndrome children after thyroxine or placebo treatment until the age of 2 years. - Neurodevelopment in Down syndrome after thyroxine treatment early in life

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON33051
Enrollment
181
Registered
2009-11-27
Start date
2009-11-15
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

"Down syndrome" en "Down's syndrome"

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 11 Years

Inclusion criteria

Inclusion criteria: See item D3.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Cognitive development determined with the *Snijders-Oomen Non-Verbale Intelligentietest-Revisie* or with the mental scale of the Dutch second version of the *Bayley Scales of Infant Development* (BSID-II, in children with a severe delay).

Secondary

MeasureTime frame
Gross Motor development determined with the *Movement Assessment Battery for Children* or with the psychomotor scale of the BSID-II (in children with a developmental age lower than 3 years). Fine Motor Development determined with the *Beery test of Visuo-Motor Integration*. Processing Speed measured with the baseline speed computer task of the *Amsterdamse Neuropsychologische Testbatterij*. Behavioural development determined with the *Vragenlijst omtrent ontwikkeling en gedrag bij kinderen*. Nerve function (conduction velocity) determined with a somatosensory evoked potentials test. Somatic growth and (pubertal) development determined with physical examination. (Spontaneous) thyroid function determined with thyroid ultrasonography and laboratory tests.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)